A randomized controlled clinical study on minimally invasive acupoint cat-embedding intervention for metabolic abnormalities of chronic kidney disease
- Conditions
- Chronic kidney disease
- Registration Number
- ITMCTR2000003830
- Lead Sponsor
- Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. It conforms to the western medicine diagnostic criteria for stage 1-3 chronic kidney disease, and according to the CKD staging criteria for stage 1-3 (eGFR>30 ml/min / 1.73 m2)
(CkD-EPI formula:
Women:
Serum creatinine <=62 mol/L eGFR (ml/min/1.73m2) =144x(SCR/62) -0.329x0.993Age
Serum creatinine & gt; 62 mol/L eGFR (ml/min/1.73m2) =144x(SCR / 62)-1.209x0.993Age
Male:
Serum creatinine <=80 mol/L eGFR (ml/min/1.73m2) =141x(SCR/80) -0.411 x 0.993Age;
Serum creatinine & gt;EGFR 80 mol/L (ml/min/1.73m2) =141x(SCR / 80)- 1.209x0.993age;
2. Aged 18-75 years old;
3. Diagnosis of metabolic syndrome (MS):
According to the international Diabetes Federation (IDF) standard and 2007 Chinese adult dyslipidemia prevention and Control guidelines, MS is defined as the presence of the following three or more components: Abdominal obesity, defined as waist circumference (WC measured from the midpoint between the lower rib and the anterior superior iliac spine) >=90cm for male and 85cm for female;Hypertriglyceridemia, defined as serum triglyceride concentration >= 1.70mmol /L,Low high-density lipoprotein cholesterol, defined as serum high-density lipoprotein cholesterol concentration HDL-C& LT; 1.04 the tendency for L; Hypertension, defined as systolic blood pressure (SBP)>=130 mm Hg, diastolic blood pressure (DBP)>=85 mm Hg, or treated with blood pressure lowering drugs; High fasting blood glucose >=6.1mmol/L or glucose load >=7.8mmol /L 2 h after meal or diabetes history;
4. Those who voluntarily accept the drug treatment and sign the informed consent.
1) Patients who are allergic to acupuncture or wire embedding, or patients who are known to be allergic to the drugs used;
2) Patients with severe primary diseases such as heart, brain, liver and hematopoietic system;
3) Patients with acute metabolic disorders such as diabetic ketoacidosis within the past month;
4) Acute renal failure patients, associated with urinary tract infection, menstrual period, intense exercise, cold and other stress states;
5) Mentally ill patients, pregnant or lactating women;
6) Those who are participating in other drug clinical trials or have participated in other clinical trials within 3 months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance index;
- Secondary Outcome Measures
Name Time Method